Moderna Plans $2 billion Convertible Senior Notes Offering
Moderna announced plans to issue $2 billion in convertible senior notes, a move to raise capital. The biotech company did not specify the use of proceeds in the brief statement. This offering represents a significant financing step for the vaccine maker.
Moderna has announced plans to issue $2 billion in convertible senior notes. The biotech company did not provide further details on the offering in its statement. This financing move comes as the company continues to navigate its post-pandemic vaccine market strategy.